Accelerate Diagnostics, Inc
AXDXDelisted Jul 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000727207
Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Accelerate Diagnostics, Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 51 | 2 | 38 | −11 |
| SharesConverted for a 1-for-10 split | 2.23M | 3.97K | 2.56M | +333.7K (+15.0%) |
| Value | $18.0M | $32.2K | $14.7M | −$3.30M (−18.3%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Accelerate Diagnostics, Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cannell Peter B & Co Inc | 114,690 | $659.5K | 0.02% |
| Chartist Inc | 67,073 | $385.7K | 0.28% |
| TCI Wealth Advisors, Inc. | 58,680 | $337.4K | 0.04% |
| Tejara Capital Ltd | 13,614 | $78.3K | 0.04% |
| Sonora Investment Management Group, LLC | 10,972 | $63.1K | 0.01% |
| Albion Financial Group | 1,712 | $9.84K | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 800 | $4.60K | 0.00% |
| Tower Research Capital LLC (TRC) | 515 | $2.96K | 0.00% |
| Qube Research & Technologies Ltd | 35 | $201 | 0.00% |
Sold out (20)
Institutions that held Accelerate Diagnostics, Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Millennium Management LLC | 123,141 | $99.7K |
| Price T Rowe Associates Inc | 63,900 | $52.0K |
| CIBC Private Wealth Group, LLC | 39,424 | $31.9K |
| Charles Schwab Investment Management Inc | 30,507 | $24.7K |
| Baird Financial Group, Inc. | 30,029 | $24.3K |
| Mariner, LLC | 29,065 | $23.5K |
| SeaCrest Wealth Management, LLC | 26,882 | $21.8K |
| Cambridge Investment Research Advisors, Inc. | 24,524 | $20.0K |
| Glenmede Trust Co NA | 20,000 | $14.0K |
| Raymond James & Associates | 16,999 | $13.8K |
| Bank of New York Mellon Corp | 14,382 | $11.6K |
| StoneX Group Inc. | 11,940 | $9.67K |
| Greenwich Wealth Management LLC | 10,800 | $9.00K |
| Stifel Financial Corp | 10,000 | $8.10K |
| BNP Paribas Arbitrage, SA | 3,102 | $2.51K |
| Group One Trading, L.P. | 2,455 | $1.99K |
| Advisor Group Holdings, Inc. | 1,734 | $1.41K |
| Simplex Trading, LLC | 1,239 | $1.00K |
| Bokf, NA | 1,000 | $810 |
| The PNC Financial Services Group, Inc. | 200 | $162 |
Not filed for Q3 2023 yet (2)
Institutions that held Accelerate Diagnostics, Inc at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Destiny Capital Corp | 38,310 | $31.0K |
| Northwest Bank & Trust Co | 1,400 | $1.13K |